Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21


Pathophysiology of Lacunar Stroke: History's Mysteries and Modern Interpretations.

Regenhardt RW, Das AS, Ohtomo R, Lo EH, Ayata C, Gurol ME.

J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2079-2097. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.006. Epub 2019 May 28. Review.


Treatment Approaches to Lacunar Stroke.

Das AS, Regenhardt RW, Feske SK, Gurol ME.

J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2055-2078. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.004. Epub 2019 May 28. Review.


Asymptomatic Cerebral Small Vessel Disease: Insights from Population-Based Studies.

Das AS, Regenhardt RW, Vernooij MW, Blacker D, Charidimou A, Viswanathan A.

J Stroke. 2019 May;21(2):121-138. doi: 10.5853/jos.2018.03608. Epub 2019 Apr 17. Review.


Advances in Understanding the Pathophysiology of Lacunar Stroke: A Review.

Regenhardt RW, Das AS, Lo EH, Caplan LR.

JAMA Neurol. 2018 Oct 1;75(10):1273-1281. doi: 10.1001/jamaneurol.2018.1073. Review.


Opportunities for intervention: stroke treatments, disability and mortality in urban Tanzania.

Regenhardt RW, Biseko MR, Shayo AF, Mmbando TN, Grundy SJ, Xu A, Saadi A, Wibecan L, Kharal GA, Parker R, Klein JP, Mateen FJ, Okeng'o K.

Int J Qual Health Care. 2019 Jun 1;31(5):385-392. doi: 10.1093/intqhc/mzy188.


Delays in the Air or Ground Transfer of Patients for Endovascular Thrombectomy.

Regenhardt RW, Mecca AP, Flavin SA, Boulouis G, Lauer A, Zachrison KS, Boomhower J, Patel AB, Hirsch JA, Schwamm LH, Leslie-Mazwi TM.

Stroke. 2018 Jun;49(6):1419-1425. doi: 10.1161/STROKEAHA.118.020618. Epub 2018 Apr 30.


Post-stroke social networks, depressive symptoms, and disability in Tanzania: A prospective study.

Saadi A, Okeng'o K, Biseko MR, Shayo AF, Mmbando TN, Grundy SJ, Xu A, Parker RA, Wibecan L, Iyer G, Onesmo PM, Kapina BN, Regenhardt RW, Mateen FJ.

Int J Stroke. 2018 Oct;13(8):840-848. doi: 10.1177/1747493018772788. Epub 2018 Apr 20.


Clinical Imaging Factors Associated With Infarct Progression in Patients With Ischemic Stroke During Transfer for Mechanical Thrombectomy.

Boulouis G, Lauer A, Siddiqui AK, Charidimou A, Regenhardt RW, Viswanathan A, Rost N, Leslie-Mazwi TM, Schwamm LH.

JAMA Neurol. 2017 Nov 1;74(11):1361-1367. doi: 10.1001/jamaneurol.2017.2149.


Blood Pressure and Penumbral Sustenance in Stroke from Large Vessel Occlusion.

Regenhardt RW, Das AS, Stapleton CJ, Chandra RV, Rabinov JD, Patel AB, Hirsch JA, Leslie-Mazwi TM.

Front Neurol. 2017 Jul 3;8:317. doi: 10.3389/fneur.2017.00317. eCollection 2017. Review.


Immediate Vascular Imaging Needed for Efficient Triage of Patients With Acute Ischemic Stroke Initially Admitted to Nonthrombectomy Centers.

Boulouis G, Siddiqui KA, Lauer A, Charidimou A, Regenhardt RW, Viswanathan A, Leslie-Mazwi TM, Rost N, Schwamm LH.

Stroke. 2017 Aug;48(8):2297-2300. doi: 10.1161/STROKEAHA.117.017607. Epub 2017 Jul 7.


Serum activity of angiotensin converting enzyme 2 is decreased in patients with acute ischemic stroke.

Bennion DM, Rosado CA, Haltigan EA, Regenhardt RW, Sumners C, Waters MF.

J Renin Angiotensin Aldosterone Syst. 2016 Aug 3;17(3). pii: 1470320316661060. doi: 10.1177/1470320316661060. Print 2016 Jul.


Activation of the Neuroprotective Angiotensin-Converting Enzyme 2 in Rat Ischemic Stroke.

Bennion DM, Haltigan EA, Irwin AJ, Donnangelo LL, Regenhardt RW, Pioquinto DJ, Purich DL, Sumners C.

Hypertension. 2015 Jul;66(1):141-8. doi: 10.1161/HYPERTENSIONAHA.115.05185. Epub 2015 May 4.


Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke.

Bennion DM, Haltigan E, Regenhardt RW, Steckelings UM, Sumners C.

Curr Hypertens Rep. 2015 Feb;17(2):3. doi: 10.1007/s11906-014-0512-2. Review.


Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice.

Sacino AN, Brooks M, Thomas MA, McKinney AB, Lee S, Regenhardt RW, McGarvey NH, Ayers JI, Notterpek L, Borchelt DR, Golde TE, Giasson BI.

Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10732-7. doi: 10.1073/pnas.1321785111. Epub 2014 Jul 7.


The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke.

Joseph JP, Mecca AP, Regenhardt RW, Bennion DM, Rodríguez V, Desland F, Patel NA, Pioquinto DJ, Unger T, Katovich MJ, Steckelings UM, Sumners C.

Neuropharmacology. 2014 Jun;81:134-41. doi: 10.1016/j.neuropharm.2014.01.044. Epub 2014 Feb 6.


Centrally administered angiotensin-(1-7) increases the survival of stroke-prone spontaneously hypertensive rats.

Regenhardt RW, Mecca AP, Desland F, Ritucci-Chinni PF, Ludin JA, Greenstein D, Banuelos C, Bizon JL, Reinhard MK, Sumners C.

Exp Physiol. 2014 Feb;99(2):442-53. doi: 10.1113/expphysiol.2013.075242. Epub 2013 Oct 18.


Cerebroprotective action of angiotensin peptides in stroke.

Regenhardt RW, Bennion DM, Sumners C.

Clin Sci (Lond). 2014 Feb;126(3):195-205. doi: 10.1042/CS20130324. Review.


Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke.

Regenhardt RW, Desland F, Mecca AP, Pioquinto DJ, Afzal A, Mocco J, Sumners C.

Neuropharmacology. 2013 Aug;71:154-63. doi: 10.1016/j.neuropharm.2013.03.025. Epub 2013 Apr 11.


Utilizing a cranial window to visualize the middle cerebral artery during endothelin-1 induced middle cerebral artery occlusion.

Regenhardt RW, Ansari S, Azari H, Caldwell KJ, Mecca AP.

J Vis Exp. 2013 Feb 22;(72):e50015. doi: 10.3791/50015.


Endothelin-1 induced middle cerebral artery occlusion model for ischemic stroke with laser Doppler flowmetry guidance in rat.

Ansari S, Azari H, Caldwell KJ, Regenhardt RW, Hedna VS, Waters MF, Hoh BL, Mecca AP.

J Vis Exp. 2013 Feb 16;(72). pii: 50014. doi: 10.3791/50014.


Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke.

Mecca AP, Regenhardt RW, O'Connor TE, Joseph JP, Raizada MK, Katovich MJ, Sumners C.

Exp Physiol. 2011 Oct;96(10):1084-96. doi: 10.1113/expphysiol.2011.058578. Epub 2011 Jun 17.

Supplemental Content

Loading ...
Support Center